Maternal control of germline development

种系发育的母体控制

基本信息

  • 批准号:
    10410366
  • 负责人:
  • 金额:
    $ 38.31万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-01 至 2024-05-31
  • 项目状态:
    已结题

项目摘要

Abstract Primordial germ cells (PGCs) are the precursors of the gametes. Defective PGC development results in reduction or elimination of germ cells and ultimately causes infertility in humans, which affects 10–15% of couples. During development, PGCs are born much earlier than the formation of the gonads. PGCs must manage to survive in the non-protective somatic environment for a long time and later migrate long distances to find the gonads. Specification of PGCs and their proliferation during early stages are crucial to ensure that sufficient number of PGCs can reach the gonads and differentiate into gametes. A large body of literature has demonstrated that before migrating into the gonads, PGC development relies heavily on translational and post-translational regulatory mechanisms. Understanding how PGC development is operated at the translational and post-translation levels thus is highly relevant to human reproductive health. My laboratory studies early PGC development using Xenopus as a model. We recently reported that maternal Dead End1 (Dnd1) is important for asymmetric localization of mRNA in the oocyte. After fertilization, Dnd1 recruits the translational machinery to nanos mRNA and promotes nanos translation. Through this mechanism, Dnd1 prevents somatic differentiation of PGCs and protects their totipotency. Our recent preliminary results reveal that Dnd1 is rapidly degraded in the oocyte by the ubiquitin- independent proteasome system. In order for Dnd1 to accumulate and promote nanos translation after fertilization, RNAs coding for proteasome activators must be separated from dnd1 and other germline specific maternal factors during the oocyte-to-embryo transition. We propose to study how this novel mRNA translocation event prepares for the initiation of PGC development after fertilization and investigate how RNAs coding for proteasome activators are separated from dnd1 and other germline specific maternal factors during the oocyte-to-embryo transition. Moreover, we have made an exciting finding that the first wave of PGC proliferation is regulated by maternal Dzip1. We will determine if Dzip1 regulates PGC proliferation via binding and modifying the activities of germline specific RNA-binding proteins. Furthermore, we will identify the zygotic transcriptional network that acts downstream of Dzip1 to control PGC proliferation. These works will make important contributions to our understanding of basic cell, reproductive, and developmental biology.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jing Yang其他文献

Jing Yang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jing Yang', 18)}}的其他基金

Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis
开发 Pleckstrin-2 小分子抑制剂来治疗血栓形成
  • 批准号:
    10545992
  • 财政年份:
    2022
  • 资助金额:
    $ 38.31万
  • 项目类别:
Functional interplay between Hippo and estrogen receptor ESR1
Hippo 和雌激素受体 ESR1 之间的功能相互作用
  • 批准号:
    10573162
  • 财政年份:
    2022
  • 资助金额:
    $ 38.31万
  • 项目类别:
Apical-basal polarity in tumor progression and metastasis
肿瘤进展和转移中的顶底极性
  • 批准号:
    10468642
  • 财政年份:
    2019
  • 资助金额:
    $ 38.31万
  • 项目类别:
Apical-basal polarity in tumor progression and metastasis
肿瘤进展和转移中的顶底极性
  • 批准号:
    10228549
  • 财政年份:
    2019
  • 资助金额:
    $ 38.31万
  • 项目类别:
2019 International EMT Society meeting
2019年国际EMT协会会议
  • 批准号:
    9914655
  • 财政年份:
    2019
  • 资助金额:
    $ 38.31万
  • 项目类别:
Maternal control of germline development
种系发育的母体控制
  • 批准号:
    10155083
  • 财政年份:
    2019
  • 资助金额:
    $ 38.31万
  • 项目类别:
Apical-basal polarity in tumor progression and metastasis
肿瘤进展和转移中的顶底极性
  • 批准号:
    10677660
  • 财政年份:
    2019
  • 资助金额:
    $ 38.31万
  • 项目类别:
Maternal control of germline development
种系发育的母体控制
  • 批准号:
    10625487
  • 财政年份:
    2019
  • 资助金额:
    $ 38.31万
  • 项目类别:
Role of integrin VLA-6 in suppression of bone formation in myeloma
整合素VLA-6在抑制骨髓瘤骨形成中的作用
  • 批准号:
    9206148
  • 财政年份:
    2016
  • 资助金额:
    $ 38.31万
  • 项目类别:
Regulation of Tumor Invasion and Metastasis by Matrix Stiffness
基质硬度对肿瘤侵袭和转移的调节
  • 批准号:
    10374409
  • 财政年份:
    2015
  • 资助金额:
    $ 38.31万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321481
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321480
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Continuing Grant
Postdoctoral Fellowship: OPP-PRF: Understanding the Role of Specific Iron-binding Organic Ligands in Governing Iron Biogeochemistry in the Southern Ocean
博士后奖学金:OPP-PRF:了解特定铁结合有机配体在控制南大洋铁生物地球化学中的作用
  • 批准号:
    2317664
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Standard Grant
Conformations of musk odorants and their binding to human musk receptors
麝香气味剂的构象及其与人类麝香受体的结合
  • 批准号:
    EP/X039420/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Research Grant
NPBactID - Differential binding of peptoid functionalized nanoparticles to bacteria for identifying specific strains
NPBactID - 类肽功能化纳米粒子与细菌的差异结合,用于识别特定菌株
  • 批准号:
    EP/Y029542/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Fellowship
Alkane transformations through binding to metals
通过与金属结合进行烷烃转化
  • 批准号:
    DP240103289
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Discovery Projects
I-Corps: Translation Potential of Real-time, Ultrasensitive Electrical Transduction of Biological Binding Events for Pathogen and Disease Detection
I-Corps:生物结合事件的实时、超灵敏电转导在病原体和疾病检测中的转化潜力
  • 批准号:
    2419915
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Standard Grant
The roles of a universally conserved DNA-and RNA-binding domain in controlling MRSA virulence and antibiotic resistance
普遍保守的 DNA 和 RNA 结合域在控制 MRSA 毒力和抗生素耐药性中的作用
  • 批准号:
    MR/Y013131/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Research Grant
CRII: OAC: Development of a modular framework for the modeling of peptide and protein binding to membranes
CRII:OAC:开发用于模拟肽和蛋白质与膜结合的模块化框架
  • 批准号:
    2347997
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Standard Grant
How lipid binding proteins shape the activity of nuclear hormone receptors
脂质结合蛋白如何影响核激素受体的活性
  • 批准号:
    DP240103141
  • 财政年份:
    2024
  • 资助金额:
    $ 38.31万
  • 项目类别:
    Discovery Projects
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了